Click to Share

Avandia Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Ennis & Ennis, P.A.
Ennis & Ennis, P.A. Explains the Recent GSK Healthcare Fraud Settlement with the Justice Department
By Jami Angelini Haggerty
Ennis & Ennis, P.A. Explains that States with a Statute of Limitations of More Than One Year for Product Liability Cases May Still Have Time to File Claims Arising from the Use of Avandia
Avandia is a drug created to help those suffering from Type II Diabetes control their blood sugars. It is a drug that has been in the news lately due to severe, potential side effects. Before taking Avandia, educate yourself and talk to your doctor.
By is expanding its exposure in New Jersey to handle the abundance of pending lawsuits in the tri-state area.
By looks to target New York state for quicker processing of funds for pending lawsuits.
By looks to expand to a second Arizona location to meet the demand for advanced funding of pending lawsuits
By to focus on California for advanced funding of pending lawsuits
By says funding for Avandia cases has exploded in September.
By is revamping its funding process for lawsuits that that have not yet settled
By Byron J. Richards, CCN
The thiazolidinedione diabetes drugs Avandia and Actos will break your bones and cause heart failure. DHA will help preserve your bones and rejuvenate your heart’s function. They all activate PPAR gamma.
By Bridgeview Legal Funding (Bridgeview Legal Funding Inc.) announces a 200% increase in July revenue on Avandia case funding.
By Dream-Maker Inc.
Thanks FDA for sending Avandia to market first for profit and then warning us about its harmful effects! FDA scientist wants Avandia pill banned. Author of United States of Arrogance shows a better, natural way to beat diabetes, live longer, stronger
By Fast Market Research
Fast Market Research recommends "Commercial Insight: Antidiabetics - DPP-IV inhibitors poised to sweep the market" from Datamonitor, now available
By Mario D Angelo
The prescription drug Avandia (rosiglitazone) causes an increase in liver problems, heart problems and bone density problems resulting in fractures.
By Dr. Matthew Mintz
Guidelines and public policy have been enacted and influenced by stakeholders with their own personal motivations and by using not entirely evidence based data to make decisions which are not in the best interest of patients with type 2 diabetes
By Katie Kelley/LegalView
LegalView provides readers with the most up-to-date information on its recently updated Avandia information portal after reports that the diabetes drug was raising the risk of osteoporosis among patients.
Avandia was the topic of discussion. A new drug available from big pharma prescription drug producers. A panel of federal advisors recently discussed whether Avandia sales should be limited.

  • 1
Page updated every 10 minutes

Like PRLog?
Click to Share